top of page
רקע ירוק למרכיבים.jpg

SALVIA OFFICINALIS  

(sage)

Has demonstrated hypoglycemic effects, potentially aiding in the reduction of fasting blood glucose levels in individuals with type 2 diabetes.Studies suggest it may enhance insulin sensitivity and modulate key enzymes involved in carbohydrate metabolism.
Additionally, sage exhibits antioxidant and anti-inflammatory properties, which can mitigate oxidative stress and systemic inflammation commonly associated with diabetes. It may also contribute to improved lipid profiles, supporting cardiovascular health in diabetic patients.

References:

Kianbakht S, Nabati F, Abasi B. Salvia officinalis (Sage) Leaf Extract as Add-on to Statin Therapy in Hypercholesterolemic Type 2 Diabetic Patients: a Randomized Clinical Trial. Int J Mol Cell Med. 2016 Summer;5(3):141-148. Epub 2016 Sep 3. 
Ben Khedher MR, Hammami M, Arch JRS, Hislop DC, Eze D, Wargent ET, Kępczyńska MA, Zaibi MS. Preventive effects of Salvia officinalis leaf extract on insulin resistance and inflammation in a model of high fat diet-induced obesity in mice that responds to rosiglitazone. PeerJ. 2018 Jan 9;6:e4166.
Abdollahi A, Adelibahram F, Ghassab-Abdollahi N, Araj-Khodaei M, Parsian Z, Mirghafourvand M. The effect of Salvia officinalis on blood glycemic indexes and blood lipid profile in diabetic patients: a systematic review and meta-analysis. J Complement Integr Med. 2022 Jan 25;20(3):521-529.

Sage.1-2022-scaled-e1663188546979.jpeg

Contact Us

logo leaf.jpg

Have a question or feedback? Feel free to reach out to us, and we'll get back to you as soon as possible.

 

© 2025 by A.M. Powered and secured by Wix 

 

* The results presented are derived from a 22-week prospective pilot study designed to clinically evaluate the effects of a combination of active food supplements (originally tested under
the name "Sugar Crush", currently marketed in the United States under a private label). The trial was conducted in a controlled research setting and is specific to the tested formulation and

conditions described in the study protocol. These findings should not be interpreted as generalizable to all populations or product variations. Real-world results may vary. The data should be

viewed in the context of the clinical trial design, population, and methodology.

bottom of page